No Data
No Data
FunPep - 1Q concludes an option agreement with Shionogi Pharmaceutical regarding the antibody-inducing peptide “FPP004X”
FunPep <4881> announced consolidated financial results for the 1st quarter (January to March 24) of the fiscal year ending 2024/12 on the 13th. Sales increased 54.8% from the same period last year to 50 billion yen, operating loss was 183 million yen (loss of 378 million yen in the same period last year), ordinary loss was 170 million yen (loss of 343 million yen), and quarterly net loss attributable to parent company shareholders was 168 million yen (341 million yen). About the antibody-inducing peptide project, the antibody-inducing peptide “FPP003” (label
Shionogi & Co FY Net Y162.03B Vs Net Y184.97B
Shionogi & Co. Ltd. (4507.TO) Osaka Year Ended March 31 GROUP 2024 2023 Revenue Y435.08 bln Y426.68 bln Operating Profit Y153.31 bln Y14
Akili Amends Strategic Distribution Agreement With Shionogi & Co. >AKLI
Akili Amends Strategic Distribution Agreement With Shionogi & Co. >AKLI
Shionogi & Co Raises FY Dividend Plan to Y160.00
Shionogi & Co. Ltd. (4507.TO) PARENT Latest Revision Previous For Year to Mar 2024 Plan Year-end Y85.00 Y75.00 Annual Y160.00 Y1
Shionogi & Co Completes Cancellation of 10.84 Million Treasury Shares
Shionogi & Co (TYO:4507) has completed the cancellation of 10.84 million treasury shares, equivalent to 3.53% of total outstanding shares before the cancellation, on April 17, according to its filing
FunPep --- signed an option agreement with Shionogi Pharmaceutical, increasing sales potential of tens of billion yen domestically alone
FunPep <4881> is a biotechnology venture established in 2013 for the purpose of putting the research results of functional peptides into practical use at Osaka University Graduate School of Medicine. We are working on the development of pharmaceuticals to replace expensive antibody pharmaceuticals using antibody-inducing peptide technology based on functional peptides developed independently. Also, in 2022/10, Anti-Aging Peptide Co., Ltd. (currently FunPep Health Care Co., Ltd.) became a subsidiary for cosmetics and other products other than pharmaceuticals
No Data